{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-093122","form_type":"8-K","ticker":"SILO","cik":"0001514183","company_name":"Silo Pharma, Inc.","filed_at":"2023-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.327261+00:00","generated_at":"2026-06-07T17:58:18.468050+00:00","sec_items":["5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Silo Pharma reduces authorized shares to 100M, adjourns annual meeting for Nevada reincorporation","bullets":["Shareholders approved decrease of authorized common stock from 500M to 100M; Certificate of Amendment filed Dec 4, 2023.","Annual meeting adjourned solely for Proposal 3 (reincorporation from Delaware to Nevada); other proposals approved.","Reconvened meeting set for Dec 11, 2023 at 11am ET in Sarasota, FL; record date Oct 12, 2023 unchanged.","Proxies already submitted will be voted on reincorporation; stockholders need not vote again."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-093122","json":"https://secwatch.observer/filing/0001213900-23-093122.json","markdown":"https://secwatch.observer/filing/0001213900-23-093122.md","text":"https://secwatch.observer/filing/0001213900-23-093122.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023093122/0001213900-23-093122-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023093122/ea189550-8k_silopharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T17:58:18.468050+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1c53acda8f6956dc592940b7999d7c8f75a52b7d","claim":"Silo Pharma, Inc.: Decreased authorized shares of common stock from 500,000,000 to 100,000,000 (effective 2023-12-04).","evidence_excerpt":"On December 4, 2023, the Company filed a Certificate of Amendment (the “Amendment”) to its Certificate of Incorporation with the Delaware Secretary of State to decrease its authorized shares of common stock from 500,000,000 shares to 100,000,000 shares.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390023093122/0001213900-23-093122-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-12-04"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}